PL377176A1 - N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony - Google Patents

N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony

Info

Publication number
PL377176A1
PL377176A1 PL377176A PL37717603A PL377176A1 PL 377176 A1 PL377176 A1 PL 377176A1 PL 377176 A PL377176 A PL 377176A PL 37717603 A PL37717603 A PL 37717603A PL 377176 A1 PL377176 A1 PL 377176A1
Authority
PL
Poland
Prior art keywords
methyleneamino
pyridones
sulfonyl
hydroxy
compounds
Prior art date
Application number
PL377176A
Other languages
English (en)
Inventor
Namal Chithranga Warshakoon
Rodney Dean Bush
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL377176A1 publication Critical patent/PL377176A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL377176A 2002-11-09 2003-11-07 N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony PL377176A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42507102P 2002-11-09 2002-11-09

Publications (1)

Publication Number Publication Date
PL377176A1 true PL377176A1 (pl) 2006-01-23

Family

ID=32312927

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377176A PL377176A1 (pl) 2002-11-09 2003-11-07 N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony

Country Status (25)

Country Link
US (3) US6946479B2 (pl)
EP (1) EP1558580B1 (pl)
JP (1) JP4327730B2 (pl)
KR (2) KR20050055793A (pl)
CN (1) CN1708482A (pl)
AT (1) ATE372986T1 (pl)
AU (1) AU2003296045B2 (pl)
BR (1) BR0316086A (pl)
CA (1) CA2502416C (pl)
CO (1) CO5570702A2 (pl)
CY (1) CY1106957T1 (pl)
DE (1) DE60316339T2 (pl)
DK (1) DK1558580T3 (pl)
ES (1) ES2293059T3 (pl)
HR (1) HRP20050517B1 (pl)
IL (1) IL168118A (pl)
MA (1) MA27549A1 (pl)
MX (1) MXPA05004897A (pl)
NO (1) NO331012B1 (pl)
NZ (1) NZ539385A (pl)
PL (1) PL377176A1 (pl)
PT (1) PT1558580E (pl)
RU (1) RU2321584C2 (pl)
WO (1) WO2004043928A2 (pl)
ZA (1) ZA200503682B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
US20070275944A1 (en) * 2006-04-05 2007-11-29 The Board Of Trustees Operating Michigan State University Antioxidants and methods of their use
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
CN105412094A (zh) 2009-07-06 2016-03-23 爱尔皮奥治疗有限公司 用于防止癌细胞转移的化合物、组合物和方法
ES2424122T3 (es) * 2009-11-06 2013-09-27 Aerpio Therapeutics Inc. Inhibidores de la prolilhidroxilasa
WO2013151584A1 (en) 2011-10-31 2013-10-10 The Methodist Hospital Research Institute Compound comprising a mao targeting/ seeker moiety for treating human gliomas
CN103360308A (zh) * 2012-03-28 2013-10-23 孙伟新 1,4-二羟基-6-甲基-2-吡啶酮类化合物及其制备方法和用途
HK1206558A1 (en) 2013-03-15 2016-01-15 Aerpio Therapeutics Inc Compositions, formulations and methods for treating ocular diseases
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
CN106232120B (zh) 2014-02-19 2021-01-08 爱尔皮奥治疗有限公司 制备n-苄基-3-羟基-4-取代的-吡啶-2-(1h)-酮的方法
EP3116503A4 (en) 2014-03-14 2017-08-23 Aerpio Therapeutics, Inc. Hptp-beta inhibitors
WO2016022813A1 (en) 2014-08-07 2016-02-11 Aerpio Therapeutics, Inc. Combination of immunotherapies with activators of tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853900A (en) 1973-09-14 1974-12-10 Searle & Co 4-benzyloxy-2 (1h)-pyridones
US5358949A (en) 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DE4316077A1 (de) 1993-05-13 1994-11-17 Bayer Ag Substituierte Mono- und Bihydridylmethylpyridone
US5817825A (en) * 1994-11-02 1998-10-06 Hoechst Aktiengesellschaft Process for the preparation of 1-hydroxy-2-pyridones
US5789426A (en) 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones

Also Published As

Publication number Publication date
EP1558580A2 (en) 2005-08-03
JP4327730B2 (ja) 2009-09-09
CO5570702A2 (es) 2005-10-31
DE60316339T2 (de) 2008-06-05
WO2004043928A8 (en) 2005-05-06
KR20050055793A (ko) 2005-06-13
JP2006513164A (ja) 2006-04-20
US20050256126A1 (en) 2005-11-17
NZ539385A (en) 2008-02-29
DK1558580T3 (da) 2008-01-14
AU2003296045A1 (en) 2004-06-03
PT1558580E (pt) 2007-12-06
ZA200503682B (en) 2006-11-29
CA2502416A1 (en) 2004-05-27
CN1708482A (zh) 2005-12-14
US6946479B2 (en) 2005-09-20
HRP20050517A2 (en) 2005-12-31
US20070238722A1 (en) 2007-10-11
KR20070030334A (ko) 2007-03-15
CY1106957T1 (el) 2012-09-26
EP1558580B1 (en) 2007-09-12
US7247632B2 (en) 2007-07-24
WO2004043928A3 (en) 2004-07-01
MA27549A1 (fr) 2005-10-03
CA2502416C (en) 2010-07-20
HRP20050517B1 (hr) 2014-03-14
RU2005114490A (ru) 2006-01-20
DE60316339D1 (de) 2007-10-25
ATE372986T1 (de) 2007-09-15
RU2321584C2 (ru) 2008-04-10
BR0316086A (pt) 2005-09-27
KR100894237B1 (ko) 2009-04-20
NO20052788L (no) 2005-06-09
AU2003296045B2 (en) 2008-04-03
WO2004043928A2 (en) 2004-05-27
US20040097559A1 (en) 2004-05-20
NO331012B1 (no) 2011-09-05
MXPA05004897A (es) 2005-11-17
ES2293059T3 (es) 2008-03-16
IL168118A (en) 2011-07-31

Similar Documents

Publication Publication Date Title
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
ECSP003699A (es) Inhibidores de fab i
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
DE60112974D1 (en) Carbolinderivate
CY1106957T1 (el) Ν-σουλφονυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακοι παραγοντες
MY138285A (en) Fab i inhibitors
EP1171428A4 (en) FAB I INHIBITORS
DE60216233D1 (en) Carbolinderivate
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
IN2012DN02609A (pl)
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
TW200508199A (en) Novel compound
UA83266C2 (en) Oxazole derivatives of tetracyclines
PL371524A1 (pl) Terapia skojarzona do leczenia zakażeń bakteryjnych
MXPA06000372A (es) Compuestos de silicio y su uso.
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
DK1648906T3 (da) Organo-silicium-forbindelser og deres anvendelse
DE60220504D1 (en) Tryptasehemmer
GB0205327D0 (en) compounds
SI1358182T1 (en) Diazocine derivates and their use as tryptase inhibitors